Adetokunbo Oluwasanjo
Medical Oncology · Lake City, FLNPI 1184937518
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,385 of the $1,664 with a category attached, or 83.2%. It is spread thinly across 33 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $879 and has fallen 96.7% since, to $29 in 2024. That places this record below the midpoint for medical oncology clinicians in FL, where the typical reported total is $8,890.
Across 85 payments — averaging $19.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$360
- AstraZeneca$128
- Seagen Inc.$98
- GSK$87
- Foundation Medicine, Inc.$84
- Sanofi$84
- plus $824 from 27 others
What the payments were for
- Food & beverage$1,38583%
- Education$27917%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 10 | $360 |
| AstraZeneca(2 entities) | 7 | $128 |
| Seagen Inc. | 6 | $98 |
| GSK | 5 | $87 |
| Foundation Medicine, Inc. | 1 | $84 |
| Sanofi | 5 | $84 |
| Novartis | 5 | $78 |
| Astellas Pharma US Inc | 5 | $75 |
| Pfizer | 4 | $72 |
| Merck | 3 | $62 |
| Incyte Corporation | 3 | $43 |
| Johnson & Johnson | 3 | $42 |
| Daiichi Sankyo Inc. | 3 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Lilly USA, LLC | 2 | $36 |
| AMAG Pharmaceuticals, Inc. | 2 | $31 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $29 |
| Genentech USA, Inc. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Boehringer Ingelheim | 1 | $25 |
| Dova Pharmaceuticals | 1 | $23 |
| Tesaro, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Karyopharm Therapeutics Inc. | 1 | $17 |
| Array Biopharma Inc | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Bayer | 1 | $15 |
| Puma Biotechnology, Inc. | 1 | $14 |
| EMD Serono, Inc. | 1 | $13 |
| Agios Pharmaceuticals, Inc. | 1 | $13 |
| Secura Bio, Inc. | 1 | $13 |
| Gilead | 1 | $12 |
| Deciphera Pharmaceuticals Inc. | 1 | $11 |
How this compares
$1,664 in reported general payments places this provider in the 20th percentile of 507 medical oncology providers in Florida.
Other medical oncology in Lake City
- Neil LoveMiami$5.6M
- Mahdi TahaBoca Raton$1.7M
- Raji ShameemOrlando$1.3M
- Mohammad JahanzebBoca Raton$1.3M
- Michel VelezOrlando$927K
- Yuanbin ChenOrlando$810K
- Reshma MahtaniPlantation$608K
- Rebecca MorooseOrlando$543K
- Yasser KhaledOrlando$444K
- Judah FriedmanPalm Beach Gardens$416K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.